MiR-19b non-canonical binding is directed by HuR and confers chemosensitivity through regulation of P-glycoprotein in breast cancer
Open Access
- 31 August 2018
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms
- Vol. 1861 (11) , 996-1006
Abstract
No abstract availableKeywords
Funding Information
- Breast Cancer Research Action Group
- British Council
- Cancer Research UK
This publication has 67 references indexed in Scilit:
- Multiple Functions of the RNA-Binding Protein HuR in Cancer Progression, Treatment Responses and PrognosisInternational Journal of Molecular Sciences, 2013
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Increased Expression of P-Glycoprotein and Doxorubicin Chemoresistance of Metastatic Breast Cancer Is Regulated by miR-298The American Journal of Pathology, 2012
- Mechanisms and Consequences of Alternative PolyadenylationMolecular Cell, 2011
- Integrative Regulatory Mapping Indicates that the RNA-Binding Protein HuR Couples Pre-mRNA Processing and mRNA StabilityMolecular Cell, 2011
- Let‐7 modulates acquired resistance of ovarian cancer to TaxanesviaIMP‐1‐mediated stabilization of multidrug resistance 1International Journal of Cancer, 2011
- Targeting Notch signalling by the conserved miR‐8/200 microRNA family in development and cancer cellsThe EMBO Journal, 2011
- The role of site accessibility in microRNA target recognitionNature Genetics, 2007
- MicroRNA Targeting Specificity in Mammals: Determinants beyond Seed PairingMolecular Cell, 2007
- A Mammalian microRNA Expression Atlas Based on Small RNA Library SequencingCell, 2007